Correlation of seizure frequency with N-acetyl-aspartate levels determined by 1H magnetic resonance spectroscopic imaging

Callaghan, 1988, Withdrawal of anticonvulsant drugs in patients free of seizures for two years, N. Engl. J. Med., 318, 942, 10.1056/NEJM198804143181502 Dodson, 1994, Quality of Life Measurements in Children with Epilepsy, 219 Hugg, 1993, Neuron loss localizes human focal epilepsy by in vivo proton MR spectroscopic imaging, Ann. Neurol., 34, 788, 10.1002/ana.410340606 Hugg, 1992, Elevated lactate and alkalosis in chronic human brain infarction observed by 1H and 31P MR spectroscopic imaging, J. Cereb. Blood Flow Metab., 12, 734, 10.1038/jcbfm.1992.104 Arnold, 1990, Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading, NMR Biomed., 3, 184, 10.1002/nbm.1940030407 Ebisu, 1994, N-acetyl-aspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging, J. Cereb. Blood Flow Metab., 14, 373, 10.1038/jcbfm.1994.48 Garcia, 1995, Proton magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy, Ann. Neurol., 37, 279, 10.1002/ana.410370222 Cendes, 1994, Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images, Ann. Neurol., 35, 211, 10.1002/ana.410350213